Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$87.2K Buy
1,725
+684
+66% +$42K ﹤0.01% 1913
2026
Q1
$67.9K Buy
1,041
+385
+59% +$28.2K ﹤0.01% 1952
2025
Q4
$52.8K Sell
656
-52
-7% -$4.18K ﹤0.01% 2049
2025
Q3
$58.1K Sell
708
-437
-38% -$37.9K ﹤0.01% 1885
2025
Q2
$104K Buy
1,145
+261
+30% +$23.3K 0.01% 1407
2025
Q1
$80.9K Buy
884
+80
+10% +$6.98K 0.01% 1434
2024
Q4
$68.5K Buy
804
+4
+0.5% +$351 0.01% 1399
2024
Q3
$70K Buy
800
+428
+115% +$36K 0.01% 1251
2024
Q2
$29.4K Buy
372
+58
+18% +$4.77K ﹤0.01% 1596
2024
Q1
$28.4K Buy
314
+44
+16% +$4.01K 0.01% 1411
2023
Q4
$24.8K Buy
+270
New +$22.5K 0.01% 1353

Other funds holding DOX

GAMMA Investing's DOX Position: Q2 2026 in Review

GAMMA Investing increased its Amdocs (DOX) stake by 66% in Q2 2026, buying an estimated $42K and bringing the position to 1,725 shares worth $87.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1913.

GAMMA Investing first reported a position in DOX in Q4 2023 and has held it in 11 quarters since. The position peaked at $104K in Q2 2025. 44 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

  • GAMMA Investing held 1,725 shares of Amdocs worth $87.2K as of Q2 2026.
  • GAMMA Investing bought 684 Amdocs shares in Q2 2026, an estimated $42K.
  • Amdocs made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #1913 holding.
  • GAMMA Investing first reported a position in Amdocs in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Amdocs position peaked at $104K in Q2 2025.
  • 44 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.